The global bone biopsy systems market is set to enjoy a valuation of US$ 227.6 million in 2022 and expand at a CAGR of 6% to reach US$ 408.9 million by the end of 2032.
Sales of bone biopsy systems accounted for more than 30% of the global bone biopsy market at the end of 2021.
Request Sample https://www.factmr.com/connectus/sample?flag=S&rep_id=3884
Segmentation of Bone Biopsy Systems Industry Research
Bone Biopsy Systems Market by Use Case :
- Bone Marrow Biopsy
- Bone Lesion Biopsy
Bone Biopsy Systems Market by Diagnostic Application :
- Bone Disorder Diagnosis
- Bone Cancer Diagnosis
- Bone Infection Detection
- Chronic Kidney Disease Diagnosis
- Others (Differentiating between Benign or Malignant tumor)
Bone Biopsy Systems Market by End User :
- Orthopedic Clinics
Bone Biopsy Systems Market by Region :
- North America
- Latin America
- East Asia
- South Asia & Oceania
Prominent bone biopsy system manufacturers are Becton, Dickinson and company, Laurane Medical, and Teleflex Incorporated.
The world’s leading manufacturers of bone biopsy products are employing innovative technologies and the optimization of systems for end users. Key manufacturers are focusing on developing new product designs to address specific problems.
- At Penn Medicine, endocrinologists are working with radiologists and oncologists to perform metabolic bone biopsy and dual-energy X-ray absorptiometry (DXA) to assist in management decisions for cancer patients.
- Becton, Dickinson Company is majorly focused on acquisitions. The company has made six acquisitions in 2021 – four in 2020 and two in 2019.
Fact.MR has provided detailed information about the price points of key manufacturers of bone biopsy systems positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.